Literature DB >> 10613797

Researchers and regulators reflect on first gene therapy death.

T Hollon.   

Abstract

Mesh:

Year:  2000        PMID: 10613797     DOI: 10.1038/71545

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  28 in total

1.  A cell-penetrating helical polymer for siRNA delivery to mammalian cells.

Authors:  Nathan P Gabrielson; Hua Lu; Lichen Yin; Kyung Hoon Kim; Jianjun Cheng
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

2.  Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?

Authors:  William M Tierney; Eric M Meslin; Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2015-08-26       Impact factor: 5.128

3.  From pharmacology to immunopharmacology.

Authors:  Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

4.  Viral vectors for vascular gene therapy.

Authors:  Lukas Fischer; Meir Preis; Anat Weisz; Belly Koren; Basil S Lewis; Moshe Y Flugelman
Journal:  Exp Clin Cardiol       Date:  2002

5.  The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures.

Authors:  Nupura S Bhise; Ryan S Gray; Joel C Sunshine; Soe Htet; Andrew J Ewald; Jordan J Green
Journal:  Biomaterials       Date:  2010-07-31       Impact factor: 12.479

6.  Novel redox nanomedicine improves gene expression of polyion complex vector.

Authors:  Kazuko Toh; Toru Yoshitomi; Yutaka Ikeda; Yukio Nagasaki
Journal:  Sci Technol Adv Mater       Date:  2011-11-18       Impact factor: 8.090

7.  Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cells.

Authors:  Jayoung Kim; Joel C Sunshine; Jordan J Green
Journal:  Bioconjug Chem       Date:  2013-12-20       Impact factor: 4.774

8.  A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.

Authors:  George H Yoo; James Moon; Michael Leblanc; Fulvio Lonardo; Susan Urba; Harold Kim; Ehab Hanna; Terry Tsue; Joseph Valentino; John Ensley; Gregory Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-09

9.  Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Authors:  Han Hsi Wong; Nicholas R Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2010-01       Impact factor: 5.818

Review 10.  Modular Cre/lox system and genetic therapeutics for colorectal cancer.

Authors:  Michael Bordonaro
Journal:  J Biomed Biotechnol       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.